info@synchemia.com | sales@synchemia.com 
9766925136 
Cobimetinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. COBIMETINIB (koe bi me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain types of melanoma, a skin cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.Cobimetinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Cobimetinib Nitroso Impurity 1 CAS NO:NAchemically represented as (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(piperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Cobimetinib Nitroso Impurity 1.We supply Cobimetinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0141047 |
| CAS No | NA |
| Mol.F. | C28H53N9O |
| Mol.Wt. | 531.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141048 |
| CAS No | NA |
| Mol.F. | C10H23N5O |
| Mol.Wt. | 229.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141049 |
| CAS No | NA |
| Mol.F. | C31H41N5O7S3 |
| Mol.Wt. | 691.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141050 |
| CAS No | NA |
| Mol.F. | C11H14ClN7O2 |
| Mol.Wt. | 311.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141051 |
| CAS No | NA |
| Mol.F. | C11H15ClN6O |
| Mol.Wt. | 282.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141052 |
| CAS No | NA |
| Mol.F. | C11H15ClN6O |
| Mol.Wt. | 282.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141053 |
| CAS No | NA |
| Mol.F. | C17H30ClN3O6S |
| Mol.Wt. | 440.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141054 |
| CAS No | NA |
| Mol.F. | C18H32ClN3O6S |
| Mol.Wt. | 454.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141055 |
| CAS No | NA |
| Mol.F. | C13H13FN4O2 |
| Mol.Wt. | 276.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141056 |
| CAS No | NA |
| Mol.F. | C21H14F4N6O3S |
| Mol.Wt. | 506.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141057 |
| CAS No | NA |
| Mol.F. | C8H8FN3O2 |
| Mol.Wt. | 197.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141058 |
| CAS No | NA |
| Mol.F. | C7H3F3N4O |
| Mol.Wt. | 216.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141059 |
| CAS No | NA |
| Mol.F. | C13H14FN3O4 |
| Mol.Wt. | 295.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141060 |
| CAS No | NA |
| Mol.F. | C16H16N6O9S2 |
| Mol.Wt. | 500.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141061 |
| CAS No | NA |
| Mol.F. | C15H16N6O7S2 |
| Mol.Wt. | 456.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141062 |
| CAS No | NA |
| Mol.F. | C16H14N6O8S2 |
| Mol.Wt. | 482.4 |
| INV STATUS | CUSTOM SYNTHESIS |
